BRIGSAFE 90MG TABLET

Product Description

BRIGSAFE 90MG TABLET is a high-quality pharmaceutical formulation containing Ticagrelor 90mg, a potent antiplatelet agent used for the prevention of thrombotic cardiovascular events. Trusted by healthcare professionals, this prescription-based medication is widely used for patients with a history of acute coronary syndrome (ACS), including myocardial infarction and unstable angina.

Manufactured under stringent quality standards, BRIGSAFE 90MG offers rapid and reversible platelet inhibition, making it a preferred choice for cardiologists and hospitals across therapeutic segments. Its mechanism of action provides superior platelet aggregation control, which helps reduce the risk of stroke and heart attack when used in combination with aspirin.

Key Benefits:

• Contains Ticagrelor 90mg: An advanced P2Y12 receptor antagonist

• Rapid onset of action with reversible binding

• Effective in reducing the risk of cardiovascular death and heart attack

• Commonly prescribed alongside low-dose aspirin

• Manufactured under GMP-certified facilities for consistent quality

• Packaged securely for bulk distribution and long shelf life

Applications & Usage:

BRIGSAFE 90MG TABLET is indicated for use in:

• Acute coronary syndrome (ACS)

• Post-angioplasty (PCI) patients

• Secondary prevention of thrombotic events

• Long-term antiplatelet therapy in high-risk cardiovascular patients

Recommended for use by licensed healthcare providers, this product should be administered under medical supervision.

Industry Keywords: antiplatelet tablet, Ticagrelor 90mg, cardiovascular medicine, ACS treatment, bulk pharmaceutical supply, hospital pharmacy product, cardiac care medication, GMP-certified pharmaceutical manufacturer, cardiology drugs, Trade India pharmaceutical distributor

Ideal For:

• Medical distributors and stockists

• Hospital procurement departments

• Chain pharmacies and bulk retailers

• Pharmaceutical exporters and B2B buyers